Featured Research

from universities, journals, and other organizations

Inhibiting Cell-Death Gene May Slow ALS Progression

Date:
July 2, 1997
Source:
Massachusetts General Hospital
Summary:
Researchers from the Massachusetts General Hospital have found that a cell-death gene may play a role in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). In the July 3Nature, they report that inhibiting the ICE cell-death gene slowed the progression of an ALS-like illness in mice.

A team of researchers from the Massachusetts General Hospital (MGH) has found evidence that a key programmed cell death gene may play a role in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease). In the July 3 issue of Nature, the team reports that inhibiting the activity of the gene coding for a protein called ICE -- the first identified mammalian cell-death gene -- slowed the progression of symptoms in mice with a gene mutation causing an ALS-like illness.

ALS is a degenerative disorder of the brain and spinal cord, which causes weakness and wasting of muscles. Patients eventually become paralyzed and die, usually within five years. The gene that causes ALS when mutated was discovered in 1993 by researchers in MGH laboratory of Robert H. Brown Jr., MD, PhD, who is a coauthor of the current Nature paper. That gene codes for production of an enzyme called superoxide dismutase (SOD1), known to neutralize dangerous chemicals called free radicals in the body.

In the current study, the MGH researchers used two strains of transgenic mice with mutations in key genes. One strain with mutations in SOD1 develops an ALS-like muscle disease. The other strain has a specific mutation called M17Z in the gene coding for the ICE protein. Discovered in 1993 by a team of researchers from the MGH and the Massachusetts Institute of Technology, the ICE gene controls some instances of programmed cell death, a natural process in which cells not necessary for normal development essentially commit suicide. The leader of the group identifying the ICE gene was Junying Yuan, PhD, also a coauthor of the Nature paper.

The researchers crossed a group of SOD1 mutant mice with a group of M17Z/ICE mutant mice and determined which of their offspring carried mutations in both genes. While mice with both mutations developed ALS-like symptoms at about the same age as those mice with the SOD1 mutation only -- about 240 days old -- the mice with both mutations lived significantly longer after disease onset than those with the single mutation -- 27 days versus almost 12 days. The results suggest that inhibiting activity of the ICE gene could slow the progression of ALS in human patients.

"This result is the first indication of the genetic pathway which mediates cell death in ALS," says Robert M. Friedlander, MD, a resident in the MGH Neurosurgical Service, who is first author of the report. "This novel insight into cell death in ALS opens a new avenue of possible therapy using drugs that inhibit the ICE cell death gene family."

Yuan, who was a member of the MGH Cardiovascular Research Center (CVRC) when this research was began, now is in the Cell Biology Department at Harvard Medical School.


Story Source:

The above story is based on materials provided by Massachusetts General Hospital. Note: Materials may be edited for content and length.


Cite This Page:

Massachusetts General Hospital. "Inhibiting Cell-Death Gene May Slow ALS Progression." ScienceDaily. ScienceDaily, 2 July 1997. <www.sciencedaily.com/releases/1997/07/970702155045.htm>.
Massachusetts General Hospital. (1997, July 2). Inhibiting Cell-Death Gene May Slow ALS Progression. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/1997/07/970702155045.htm
Massachusetts General Hospital. "Inhibiting Cell-Death Gene May Slow ALS Progression." ScienceDaily. www.sciencedaily.com/releases/1997/07/970702155045.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins